Brief: CERo Therapeutics Announces Completion Of First Cohort Of Phase 1 Clinical Trial Of Cer-1236 In Aml
13/10/2025 13:32
Oct 13 (Reuters) - CERo Therapeutics Holdings Inc CERO.O: CERO THERAPEUTICS ANNOUNCES COMPLETION OF FIRST COHORT OF PHASE 1 CLINICAL TRIAL OF CER-1236 IN AML CERO THERAPEUTICS HOLDINGS INC - ASSERTS IT IS NOT FOR SALE OR SEEKING PARTNERSHIPS Source text: ID:nGNX2GJwF5 Further company coverage: CERO.O (Reporting by Anhata Rooprai) ((Anhata.Rooprai@thomsonreuters.com;))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List